Paul McBarron, EVP, Finance, CFO, COO at Cyclacel Pharmaceuticals, Inc. (CYCC), bought 12,948 shares at $3.00 ($39K) on 2013-05-21, disclosed to the SEC on 2013-05-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.00 | 8,333 | $25K | 63.8% |
| 2 | $3.08 | 4,615 | $14K | 36.2% |
| Total | $3.03 avg | 12,948 | $39K | 100% |
| Filing → |
| CYCC | BUY | 2008-05-23 | $4K | — | Filing → |